Indeed, RCC-41-PDX-2/CD133+ formed smaller palpable tumors (100 mm3) detected in the injected mice after 9 weeks and only at the concentration of 103 cells per mouse (Figure 6). This evidence concerns the gene PROM1 and renal cell carcinoma.